Sign Up to like & get
recommendations!
2
Published in 2022 at "European Journal of Heart Failure"
DOI: 10.1002/ejhf.2492
Abstract: Transcatheter mitral valve implantation (TMVI) represents a novel treatment option for patients with mitral regurgitation (MR) unsuitable for established therapies. The CHOICE‐MI registry aimed to investigate outcomes of patients undergoing screening for TMVI.
read more here.
Keywords:
outcomes patients;
choice registry;
valve implantation;
mitral valve ... See more keywords